Your browser doesn't support javascript.
loading
The discovery and validation of new drug targets in cancer.
Courtneidge, S A; Plowman, G D.
Afiliación
  • Courtneidge SA; SUGEN Inc. 230 East Grand Avenue South San Francisco CA 94080 USA. sara-courteneidge@sugen.com.
Curr Opin Biotechnol ; 9(6): 632-6, 1998 Dec.
Article en En | MEDLINE | ID: mdl-9889138
Advances in our understanding of the signal transduction pathways involved in cellular growth control have provided several new strategies for cancer therapy. Recent advances now make it possible to develop selective inhibitors targeting genomic instability, the growth, survival, and invasion of the tumor, and its nourishment through the growth of new blood vessels.
Asunto(s)
Buscar en Google
Banco de datos: MEDLINE Asunto principal: Diseño de Fármacos / Neoplasias / Antineoplásicos Límite: Animals / Humans Idioma: En Revista: Curr Opin Biotechnol Asunto de la revista: BIOTECNOLOGIA Año: 1998 Tipo del documento: Article
Buscar en Google
Banco de datos: MEDLINE Asunto principal: Diseño de Fármacos / Neoplasias / Antineoplásicos Límite: Animals / Humans Idioma: En Revista: Curr Opin Biotechnol Asunto de la revista: BIOTECNOLOGIA Año: 1998 Tipo del documento: Article